High Efficacy of Vonoprazan—Based First—Line and Second—Line Eradication Therapy for Helicobacter pylori Infection Has Been Maintained Since 2015 in Japan

Authors :: Hitoshi Ogasawara
Kiyonori Yamai
Shinsaku Fukuda
Tadashi Shimoyama
Daisuke Chinda
Source :: American Journal of Gastroenterology. 113:S700
Publication Year :: 2018
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2018.

Subjects :: Helicobacter pylori infection
Second line
Hepatology
Vonoprazan
business.industry
First line
Gastroenterology
Medicine
business
Virology

Tools